IP Verse
Top Law Firms
Unified Patent Court
Trending Technologies
Blogs
Contact Us
Toggle menu
Arog Pharmaceuticals, Inc. opposition analysis
COMPANY ANALYSIS
Latest patents of Arog Pharmaceuticals, Inc. opposed by its competitors
Patent:
EP2941251
Grant Date:
Mar 7, 2018
Title:
Crenolanib For Treating Flt3 Mutated Proliferative Disorders
Oppositions:
1
Latest patents of Arog Pharmaceuticals, Inc. opposed by its competitors
Patent Number
Grant Date
Title
Total Oppositions
EP2941251
Mar 7, 2018
Crenolanib For Treating Flt3 Mutated Proliferative Disorders
1
Competitors of Arog Pharmaceuticals, Inc.
HEXAL PHARMA AG
Want to track Arog Pharmaceuticals, Inc.?
Feel free to send us a message here and we will get back to you
Name
Email
Message
Let's get in touch